Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1949 1
1950 1
1951 2
1952 1
1953 1
1954 4
1955 4
1956 1
1958 1
1959 3
1960 2
1961 3
1962 5
1963 3
1964 2
1965 8
1966 2
1967 2
1969 6
1970 6
1971 2
1972 5
1973 7
1974 9
1975 6
1976 3
1977 6
1978 3
1979 8
1980 8
1981 7
1982 4
1983 9
1984 17
1985 30
1986 15
1987 29
1988 29
1989 32
1990 39
1991 25
1992 33
1993 33
1994 59
1995 47
1996 48
1997 49
1998 49
1999 56
2000 66
2001 73
2002 58
2003 64
2004 70
2005 87
2006 90
2007 92
2008 93
2009 114
2010 85
2011 113
2012 117
2013 110
2014 122
2015 123
2016 128
2017 141
2018 178
2019 170
2020 165
2021 164
2022 155
2023 169
2024 118
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,254 results

Results by year

Filters applied: . Clear all
Page 1
CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis.
Minami JK, Morrow D, Bayley NA, Fernandez EG, Salinas JJ, Tse C, Zhu H, Su B, Plawat R, Jones A, Sammarco A, Liau LM, Graeber TG, Williams KJ, Cloughesy TF, Dixon SJ, Bensinger SJ, Nathanson DA. Minami JK, et al. Among authors: fernandez eg. Cancer Cell. 2023 Jun 12;41(6):1048-1060.e9. doi: 10.1016/j.ccell.2023.05.001. Epub 2023 May 25. Cancer Cell. 2023. PMID: 37236196 Free PMC article.
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial.
Subbiah V, Kreitman RJ, Wainberg ZA, Gazzah A, Lassen U, Stein A, Wen PY, Dietrich S, de Jonge MJA, Blay JY, Italiano A, Yonemori K, Cho DC, de Vos FYFL, Moreau P, Fernandez EE, Schellens JHM, Zielinski CC, Redhu S, Boran A, Passos VQ, Ilankumaran P, Bang YJ. Subbiah V, et al. Among authors: fernandez ee. Nat Med. 2023 May;29(5):1103-1112. doi: 10.1038/s41591-023-02321-8. Epub 2023 Apr 14. Nat Med. 2023. PMID: 37059834 Free PMC article. Clinical Trial.
Generation and multi-dimensional profiling of a childhood cancer cell line atlas defines new therapeutic opportunities.
Sun CX, Daniel P, Bradshaw G, Shi H, Loi M, Chew N, Parackal S, Tsui V, Liang Y, Koptyra M, Adjumain S, Sun C, Chong WC, Fernando D, Drinkwater C, Tourchi M, Habarakada D, Sooraj D, Carvalho D, Storm PB, Baubet V, Sayles LC, Fernandez E, Nguyen T, Pörksen M, Doan A, Crombie DE, Panday M, Zhukova N, Dun MD, Ludlow LE, Day B, Stringer BW, Neeman N, Rubens JA, Raabe EH, Vinci M, Tyrrell V, Fletcher JI, Ekert PG, Dumevska B, Ziegler DS, Tsoli M, Syed Sulaiman NF, Loh AHP, Low SYY, Sweet-Cordero EA, Monje M, Resnick A, Jones C, Downie P, Williams B, Rosenbluh J, Gough D, Cain JE, Firestein R. Sun CX, et al. Among authors: fernandez e. Cancer Cell. 2023 Apr 10;41(4):660-677.e7. doi: 10.1016/j.ccell.2023.03.007. Epub 2023 Mar 30. Cancer Cell. 2023. PMID: 37001527 Free article.
Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators.
Obradovic A, Ager C, Turunen M, Nirschl T, Khosravi-Maharlooei M, Iuga A, Jackson CM, Yegnasubramanian S, Tomassoni L, Fernandez EC, McCann P, Rogava M, DeMarzo AM, Kochel CM, Allaf M, Bivalacqua T, Lim M, Realubit R, Karan C, Drake CG, Califano A. Obradovic A, et al. Among authors: fernandez ec. Cancer Cell. 2023 May 8;41(5):933-949.e11. doi: 10.1016/j.ccell.2023.04.003. Epub 2023 Apr 27. Cancer Cell. 2023. PMID: 37116491 Free PMC article.
Dupilumab-Associated Sweet Syndrome.
Fernandez E, Chandler W, Long PR, Palmer ML, Fadugba O. Fernandez E, et al. Cutis. 2023 Jun;111(6):E7-E9. doi: 10.12788/cutis.0798. Cutis. 2023. PMID: 37487126
Smoking-attributable mortality in Spain: Quo Vadis?
Pérez-Ríos M, Fernández E, López MJ. Pérez-Ríos M, et al. Among authors: fernandez e. Arch Bronconeumol. 2021 Aug;57(8):515-516. doi: 10.1016/j.arbr.2021.05.021. Epub 2021 May 26. Arch Bronconeumol. 2021. PMID: 34052194 No abstract available.
N-Terminal Proteoforms in Human Disease.
Bogaert A, Fernandez E, Gevaert K. Bogaert A, et al. Among authors: fernandez e. Trends Biochem Sci. 2020 Apr;45(4):308-320. doi: 10.1016/j.tibs.2019.12.009. Epub 2020 Jan 27. Trends Biochem Sci. 2020. PMID: 32001092 Free article. Review.
Recurrent Glioblastoma: A Review of the Treatment Options.
Vaz-Salgado MA, Villamayor M, Albarrán V, Alía V, Sotoca P, Chamorro J, Rosero D, Barrill AM, Martín M, Fernandez E, Gutierrez JA, Rojas-Medina LM, Ley L. Vaz-Salgado MA, et al. Among authors: fernandez e. Cancers (Basel). 2023 Aug 26;15(17):4279. doi: 10.3390/cancers15174279. Cancers (Basel). 2023. PMID: 37686553 Free PMC article. Review.
Astaxanthin and meclizine extend lifespan in UM-HET3 male mice; fisetin, SG1002 (hydrogen sulfide donor), dimethyl fumarate, mycophenolic acid, and 4-phenylbutyrate do not significantly affect lifespan in either sex at the doses and schedules used.
Harrison DE, Strong R, Reifsnyder P, Rosenthal N, Korstanje R, Fernandez E, Flurkey K, Ginsburg BC, Murrell MD, Javors MA, Lopez-Cruzan M, Nelson JF, Willcox BJ, Allsopp R, Watumull DM, Watumull DG, Cortopassi G, Kirkland JL, Tchkonia T, Choi YG, Yousefzadeh MJ, Robbins PD, Mitchell JR, Acar M, Sarnoski EA, Bene MR, Salmon A, Kumar N, Miller RA. Harrison DE, et al. Among authors: fernandez e. Geroscience. 2024 Feb;46(1):795-816. doi: 10.1007/s11357-023-01011-0. Epub 2023 Dec 2. Geroscience. 2024. PMID: 38041783 Free PMC article.
3,254 results